ClinicalTrials.govpublic full text
A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
acute t cell lymphoblastic leukemia, lymphoblastic lymphoma (precursor t-lymphoblastic lymphoma/leukaemia) refractory, acute myeloid leukemia (aml), t cell lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 864620
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.